Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose

por Wallerstein, Avi, Jackson, W Bruce, Chambers, Jeffrey, Moezzi, Amir M, Lin, Hugh, Simmons, Peter A
Publicado 2018

TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration

por Khanani, Arshad M., Guymer, Robyn H., Basu, Karen, Boston, Heather, Heier, Jeffrey S., Korobelnik, Jean-François, Kotecha, Aachal, Lin, Hugh, Silverman, David, Swaminathan, Balakumar, Willis, Jeffrey R., Yoon, Young Hee, Quezada-Ruiz, Carlos
Publicado 2021

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE...

por Takahashi, Kanji, Cheung, Chui Ming Gemmy, Iida, Tomohiro, Lai, Timothy Y. Y., Ohji, Masahito, Yanagi, Yasuo, Kawano, Mika, Ohsawa, Shino, Suzuki, Tomoyuki, Kotecha, Aachal, Lin, Hugh, Patel, Vaibhavi, Swaminathan, Balakumar, Lee, Won Ki
Publicado 2023

YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale

por Eter, Nicole, Singh, Rishi P., Abreu, Francis, Asik, Kemal, Basu, Karen, Baumal, Caroline, Chang, Andrew, Csaky, Karl G., Haskova, Zdenka, Lin, Hugh, Ruiz, Carlos Quezada, Ruamviboonsuk, Paisan, Silverman, David, Wykoff, Charles C., Willis, Jeffrey R.
Publicado 2021